Research Repository

Reply to 'Not credible: A subversion of science by the pharmaceutical industry. Commentary on A global comparison regarding patient access to cancer drugs (Annals of Oncology 2007, vol 18, Suppl 3, pp1-75)' by Michel P Coleman

Jönsson, B, Lichtenberg, Frank and Wilking, N (2007) Reply to 'Not credible: A subversion of science by the pharmaceutical industry. Commentary on A global comparison regarding patient access to cancer drugs (Annals of Oncology 2007, vol 18, Suppl 3, pp1-75)' by Michel P Coleman. Annals of Oncology, 18 (9). 1585 - 1587. ISSN 0923-7534

Full text for this resource is not available from the Research Repository.

Abstract

Letter to the editor in response to: Not credible: A subversion of science by the pharmaceutical industry. Commentary on A global comparison regarding patient access to cancer drugs / Michel P Coleman, Annals of Oncology, vol 18, Suppl 3, pp. 1-75, 2007.

Item Type: Article
Uncontrolled Keywords: patient access; cancer drugs; national cancer drug licensing; eISSN 1569-8041
Subjects: Current > FOR Classification > 1112 Oncology and Carcinogenesis
Current > Division/Research > College of Business
Depositing User: Symplectic Elements
Date Deposited: 13 Jan 2017 07:03
Last Modified: 13 Jan 2017 07:03
URI: http://vuir.vu.edu.au/id/eprint/31729
DOI: https://doi.org/10.1093/annonc/mdm397
ePrint Statistics: View download statistics for this item
Citations in Scopus: 2 - View on Scopus

Repository staff only

View Item View Item

Search Google Scholar